| | | | |

Patient Lyme disease websites prioritize science; public health websites prioritize consistent messaging—Comment on ‘Lyme disease prevention: A content analysis of Canadian patient group and government websites’

ByCanLyme Team

Dear Editor, A recent article ‘Lyme disease prevention: A content analysis of Canadian patient group and government websites’ by Journault et al. (2020) in Zoonoses and Public Health describes content analysis of three public health and three patient group Lyme disease websites with respect to information on prevention of infection. The (relatively few) divergent items…

| | | | | | | | | | | | | | | |

Canada implicated once again in covert non-transparent manipulation of World Health Organization

ByCanLyme Team

When will the corruption stop? CanLyme is a member of the Ad Hoc Committee for Health Equity. “A request to have ‘Congenital Lyme borreliosis’ listed as a ‘stand-alone’ category in the new ICD-11 codes was made by the Ad Hoc Committee for Health Equity in ICD-11 Borreliosis Codes, submitted March 27, 2017 by Jenna Luché-Thayer…

| | | | |

1990 archive, MacLean’s magazine: A growing menace

ByCanLyme Team

[CanLyme Note: Here we are 30 years later since the formation of the Lyme Borreliosis Society of BC, later rolled into CanLyme, and our government funded agencies with their bureaucrats collude with private medical associations (IDSA, AMMI, CPS), pharma, and medical insurers to deny access to appropriate diagnosis and care to hundreds of thousands. Our…

| | | | | | | | | | | | | | | |

Global TV News: Why Lyme disease is on the rise, explained

ByCanLyme Team

[CanLyme Note: Both AIDS and Lyme disease arose as an issue in the late 1970’s with the first case of Lyme reported in Quebec in 1977. As pointed out in this piece, since then there have been over 11,000 clinical trials for AIDS yet only 60 for Lyme disease. Lyme disease research funding in Canada…

| | | | | |

The new draft of the Infectious Disease Society of America (IDSA) guidelines open for public comment for 45 days.

ByCanLyme Team

The IDSA has presented their draft guidelines which with a brief scan appear not much different then their old controversial poorly evidenced guidelines.  Much of the same old players and 3 token patients. Typical unequal representation. Public comments close August 10th. Take your time, make notes before you enter their controlled comment format process as…

| | | | | |

The Scientist – Opinion: The “Money Culture” in Academic Biomedical Research

ByCanLyme Team

[CanLyme Note: This for profit money drive takes medical research away from cure to ‘a drug for every symptom’. In Canada, relative to Lyme disease, the private Association of Medical Microbiology and Infectious Disease of Canada (AMMI), is an extension of the ‘do not cure’ medical money machine. They offer opinion and poorly designed research to…

| | | | | | | | | | | | | | | |

Lyme advocates say Canada offers “toxic tokenism” to patients

ByCanLyme Team

The Canadian government recently announced new investment in Lyme disease research. However, Canadian Lyme advocates fear that the patient voice will be excluded from the decision-making process. In the following article, the Canadian Lyme Consortium (CLC)–made up of advocates, patients, researchers and practitioners–offers background and context. By Vett Lloyd, PhD; Liz Zubek, MD, CCFP FCFP; Sue Faber and Jennifer Kravis,…

| | | | | | |

Interview: The flawed science behind the current global Lyme policies, diagnostics and treatment

ByCanLyme Team

Posted on on-lyme.org Dec 2nd, 2017  Written by Huib Holly Ahern is a professor of microbiology as well as the mother of a child that was severely affected by Lyme Disease. Because of this personal experience and her professional background and training, she was able to dissect the flaws in scientific reasoning that underlie decades of…

| | | | |

Human seroprevalence of Borrelia miyamotoi in Manitoba, Canada, in 2011–2014: a cross-sectional study

ByCanLyme Team

[CanLyme Note: This is a very interesting and important study and we are pleased that this is being looked at but there are some glaring omissions in the document. Not made clear in the results is that a significant percentage of obviously symptomatic patients (why their blood was tested in the first place) would be completely…

| | | | | | | |

Anti-science old guard taking last dying breaths of continuing to misinform physicians using tax payer dollars

ByCanLyme Team

Here is their opinion article title, amazing in 2017 how poorly they reference their evidence… “False and Misleading Information about Lyme Disease”   Here is one of their uniformed statements, “Persistent, unexplained subjective symptoms such as chronic fatigue and pain are common in the general population. Annual surveys by the Centers for Disease Control and…

| | | | |

Flunk the Lyme test? Just wait and get sicker

ByCanLyme Team

January, 2017, Huffington Post Sin Lee, a pathologist and scientist, believes the deck is stacked in the quest to air new ideas on Lyme disease. Too many science journals telling him to take his research elsewhere. Too many deftly worded rejections. Too little inclination to engage in a fair fight over the facts and fiction…

| | | | | |

CanLyme director responds to Canadian Medical Association Journal article

ByTeam

Response to Doctors Gregson and Quach Robert G. Murray, DDS, Director, CanLyme Re: “The Lyme law” Zubek, 187:520-521doi:10.1503/cmaj.115-0029 The problem with Lyme disease in Canada will only continue to grow to the point where the numbers affected will simply overwhelm the idea that Lyme Borreliosis (LB) is hard to catch and easy to treat with…

| | | | | | |

Doctor comments on Lyme disease treatment

ByTeam

[CanLyme note: It is very common for mainstream physicians who subscribe to the Infectious Disease Society of America guidelines to design studies in such a fashion that the outcome is pre-determined.  These studies have no value, nor scientific merit.  The divide is created intentionally.] Infectious Disease doctor, Sam Donta, responds to article, To the Editor:…

| | | | | | |

A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library

ByTeam

Frontiers in Microbiology, May 23, 2016 Although currently recommended antibiotics for Lyme disease such as doxycycline or amoxicillin cure the majority of the patients, about 10–20% of patients treated for Lyme disease may experience lingering symptoms including fatigue, pain, or joint and muscle aches. Under experimental stress conditions such as starvation or antibiotic exposure, Borrelia…

| | | | | | | | | | | | | | | |

Watch CTV news interview of Dr. Todd Hatchette. A very good example of how opinion, not science, is driving Lyme borreliosis policy in Canada… in spite of evidence presented by experts in Ottawa, May 15th to 17th, 2016.

ByTeam

[Lyme disease is actually Lyme borreliosis. an infection caused by many different strains/genotypes of Borrelia bacteria] How can one rationalize making progress from the patient’s expert perspective when officially, by tax payer funded microbiologists, opinion is put forward as fact with no supporting science. Dr. Todd Hatchette attended the recent three day conference in Ottawa…